| Literature DB >> 29375181 |
Abstract
Keywords: Pharmaceutical Benefits Scheme; dabigatran; drug promotion; medicine access programs
Year: 2017 PMID: 29375181 PMCID: PMC5768595 DOI: 10.18773/austprescr.2017.076
Source DB: PubMed Journal: Aust Prescr ISSN: 0312-8008